What Is CBD Oil
Charlotte Figi was three months old when she had her first epileptic seizure. The episode appeared to come out of nowhere, as Charlotte's early infancy, as well as her fraternal twin's first few months, had been smooth sailing up until that point. As her parents, Matt and Paige, stood by, alarmed and concerned, Charlotte underwent a battery of medical tests, including bloodwork, MRIs, spinal taps and more. All her results were normal. And yet, a week later, Charlotte experienced her second, more intense seizure. Fast forward two years and toddler Charlotte's life had been taken over by daily seizures, stalled cognitive development, emotional changes and fruitless medical tests. Just before her third birthday, the Figis finally got some insight into what could be at the root of Charlotte's problems: doctors at Children's Hospital in Colorado diagnosed her with a condition called Dravet syndrome (also known as myoclonic epilepsy). The incurable, severe form of epilepsy is part of a group of diseases called SCN1A-related seizure disorders and while it typically develops in the first year of life, it causes longer, more intense seizures as time goes on.
The resulting damage can include behavioral, cognitive, and emotional trauma that stunts growth and can even result in premature death. They considered off-label medications, dietary changes, acupuncture and more, but nothing worked. By the time Charlotte was six, she was experiencing over 300 epileptic episodes a week and was unable to move, talk or eat on her own. By the time doctors suggested a medically induced coma, the Figis were at their breaking point. It was then that Matt came across a video describing the possible therapeutic benefits of cannabis, particularly CBD. What Is CBD Oil? Otherwise known as cannabidiol, Garden CBD Relief is the second most prevalent active ingredient in cannabis (aka marijuana), next to delta-9-tetrahydrocannabinol (THC). Most people are familiar with the effects of THC - it's the part of the cannabis plant that's known to have mind-altering (psychoactive) effects, causing everything from feelings of euphoria and relaxation to short-term memory problems and hallucinations. Deanie Elsner, CEO of Charlotte's Web, a high-CBD, low-THC cannabis strain that played a major role in the Figis' story. It's helped everything. She has over 99 percent seizure control. She doesn't use her feeding tube anymore; she was 100 percent tube-fed before. She doesn't have her autistic behavior anymore, and she doesn't have severe sleep disorders. She can walk - she's not in her wheelchair at all - and she's talking. She couldn't talk before, and now she's talking. Our biggest hope as a company is that we will continue to have the opportunity to give back to the people of this page earth," Elsner says. "We're anticipating far more research into the category, and Nature’s Garden CBD Gummies into hemp in general, which is very exciting. Humanity barely knows how valuable hemp can be.
globalgreyebooks.com
Nature’s Garden CBD Gummies (cannabidiol) and THC (tetrahydrocannabinol) are the two major compounds found in the cannabis plant. Each has unique properties, potential health benefits, and side effects. The following article covers CBD and THC, their effects, their legal status, and their safety considerations. CBD and THC are known as cannabinoids. They have very similar chemical structures and activate the same receptors within the body’s endocannabinoid system. Despite their similarity in structure, CBD and THC exert entirely different effects. The most significant difference between these two compounds is that THC is psychoactive. This means it can affect how the brain works. THC activates the body’s "reward" pathways to produce the "high" that’s associated with marijuana use. It does this by activating a cannabinoid receptor called CB1. When THC activates this type of receptor, things like movement, body temperature, and brain function are affected. In contrast, CBD is not considered psychoactive. It does not cause euphoria or a "high," even at large doses.
Much of the research on CBD and THC is preclinical, meaning it’s been studied in animal models. Large-scale human trials are necessary to determine if CBD or THC can help treat most of these conditions. Though it does act on cannabinoid receptors, CBD mainly affects other receptors, including serotonin receptors. It may help counteract some of the negative effects of THC, including serious side effects like psychosis. CBD has many purported therapeutic properties. Pain. Overall, there isn’t enough evidence that CBD by itself helps with pain. Some research has shown that high doses can improve neuropathy (nerve pain), though more data is necessary. Anxiety. So far, the results are mixed. Some studies show that CBD can improve symptoms of social anxiety disorder and post-traumatic stress disorder (PTSD), while others show no effect. Seizures. Epidiolex, a purified CBD oil, is approved by the Food and Drug Administration (FDA) for some hard-to-treat types of childhood epilepsy.
Brain protection. Animal studies have shown that CBD may have benefits for those who have Alzheimer’s disease or Parkinson’s disease, but human clinical trials are necessary to verify these effects. Effects on animals may or may not translate into benefits for humans. THC is the psychoactive ingredient from the marijuana plant. The possession and use of marijuana and THC-containing products are not legal in all U.S. THC is effective for increasing appetite and for nausea and vomiting related to cancer chemotherapy. Pain. Prescription THC products have been shown to improve neuropathy and quality of life. Spasticity (muscle tightness). Sativex (nabiximols), a mouth spray that combines THC and CBD, is approved for spasticity in Europe. PTSD. A very small trial found that Cesamet reduced nightmares in 10 military personnel with PTSD. Irritable bowel syndrome (IBS). Smoking THC was found to improve symptoms of IBS, but benefits may be only short-lived. People who used THC long-term were more likely to ultimately require surgery for IBS.
